Matrix Metalloproteinase Expression Levels Suggest Distinct Enzyme Roles During Lumbar Disc Herniation and Degeneration
Overview
Authors
Affiliations
The disruption of the extracellular disc matrix is a major hallmark of disc degeneration. This has previously been shown to be associated with an up-regulation of major matrix metalloproteinase (MMP) expression and activity. However, until now hardly any data are available for MMP/TIMP regulation and thereby no concept exists as to which MMP/TIMP plays a major role in disc degeneration. The objective of this study was, therefore, to identify and quantify the putative up-regulation of MMPs/TIMPs on the mRNA and protein level and their activity in disc material in relation to clinical data and histological evidence for disc degeneration. A quantitative molecular analysis of the mRNA expression levels for the MMPs (MMPs-1, -2, -3, -7, -8, -9, -13) and the MMP inhibitors (TIMPs-1 and -2) was performed on 37 disc specimens obtained from symptomatic disc herniation or degeneration. In addition, disc specimens from patients without disc degeneration/herniation (=controls) were analyzed. Expression of MMPs-1, -2, -3, -7, -8, -9, -13 and TIMPs-1, -2 was analyzed using quantitative RT-PCR, normalized to the expression level of a house keeping gene (GAPDH). Gene expression patterns were correlated with MMP activity (in situ zymography), protein expression patterns (immunohistochemistry), degeneration score (routine histology) and clinical data. MMP-3 mRNA levels were consistently and substantially up-regulated in samples with histological evidence for disc degeneration. A similar but less pronounced up-regulation was observed for MMP-8. This up-regulation was paralleled by the expression of TIMP-1 and to a lesser extent TIMP-2. In general, these findings could be confirmed with regard to protein expression and enzyme activity. This study provides data on the gene and protein level, which highlights the key role of MMP-3 in the degenerative cascade leading to symptomatic disc degeneration and herniation. Control of the proteolytic activity of MMP-3 may, therefore, come into the focus when aiming to develop new treatment options for early disc degeneration.
Zhang X, Li G, Tan F, Yu T, Xu C, Li K PLoS One. 2025; 20(1):e0314021.
PMID: 39752341 PMC: 11698339. DOI: 10.1371/journal.pone.0314021.
Ni Neill T, Barcellona M, Wilson N, OBrien F, Dixon J, Curtin C JOR Spine. 2024; 7(4):e1366.
PMID: 39726900 PMC: 11669629. DOI: 10.1002/jsp2.1366.
Kulesza M, Guszczyn T, Kicman A, Lawicki S J Clin Med. 2024; 13(19).
PMID: 39407715 PMC: 11477660. DOI: 10.3390/jcm13195655.
Mengis T, Bernhard L, Nuesch A, Heggli I, Herger N, Devan J Cells. 2024; 13(17.
PMID: 39272974 PMC: 11394474. DOI: 10.3390/cells13171402.
Getting to the Core: Exploring the Embryonic Development from Notochord to Nucleus Pulposus.
Ambrosio L, Schol J, Ruiz-Fernandez C, Tamagawa S, Joyce K, Nomura A J Dev Biol. 2024; 12(3).
PMID: 39051200 PMC: 11270426. DOI: 10.3390/jdb12030018.